Primary monocympetic nocturnal enuresis. Nacturnal enuresis
Conditions
Interventions
Intervention 1: Control group: Patients will be randomly divided into two groups: (CCTT) by random allocation with variable blocks that create six different states. CTCT. CTTC. TTCC TCTC. (TCCT) and t
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 16 Years
Inclusion criteria
Inclusion criteria: Patients have monosymptomatic primary enuresis. Patients without any anatomical disorder of kidney in sonography Patients aged 5 -16 years Knowledgeably compliance for entry or exit from research
Exclusion criteria
Exclusion criteria: Patients with enuresis with symptoms of daily urinary disorders, such as urgent urinary incontinence, frequent urination, or reduced urination frequency per day, urinary retention maneuvers during the day. Patients with urinary tract infection (positive urine culture), fasting blood sugar, renal dysfunction (high creatinine), Anatomical abnormalities of the kidney on ultrasound, patients previously treated for enuresis patients with incomplete information, and no referrals if the child does not have enuresis (has gained control of urination) and later has enuresis secondary enuresis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nocturnal enuresis. Timepoint: After starting treatment, patients will be visited monthly. If there is a partial or no response up to two weeks after treatment, possible factors of resistance to treatment such as constipation, bladder disorders or not taking the drug properly will be investigated. Failure to respond to treatment refers to one or more night wetting in two consecutive weeks during treatment and response to treatment is defined as dryness in two consecutive weeks.After three months of treatment, the drugs are discontinued overnight for one month. Re-visits are performed two weeks after treatment and recurrence of nocturnal enuresis (more than three nights wetting per week) will be checked. Method of measurement: Response to treatment questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Early enuresis recurrence. Timepoint: En After starting treatment, patients will be visited monthly. If there is a partial or no response up to two weeks after treatment, possible factors of resistance to treatment such as constipation, bladder disorders or not taking the drug properly will be investigated. Failure to respond to treatment refers to one or more night wetting in two consecutive weeks during treatment and response to treatment is defined as dryness in two consecutive weeks.After three months of treatment, the drugs are discontinued overnight for one month. Re-visits are performed two weeks after treatment and recurrence of nocturnal enuresis (more than three nights wetting per week) will be checked. Method of measurement: En Response to treatment questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFereshteh Sobhani
Qazvin University of Medical Sciences
Outcome results
None listed